Trademark Encyclopedia

Information about trademarks

Search for trademarks:

• 0
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

Table of contents:

• Document 85583345 overview
• GOODS AND/OR SERVICES CLASS
• FOREGIN REGISTRATION
• DESIGN CODES
• PROSECUTION HISTORY
• Document 85583366 overview
• GOODS AND/OR SERVICES CLASS
• FOREGIN REGISTRATION
• PROSECUTION HISTORY

---

---

The "MOLECULARHEALTH" trademark, serial number 85583345 , was filed on 29th of March 2012 with a mark drawing code of 3000 and its transaction date is 85583345. The attorney assigned is Nicole E. Gage, attorney docket number 073044-TBA. Since 20th of March 2014, the document can be found in the L50 law office in the publication and issue section. The date when we last checked the status of this trademark was 03/20/2014.

The corresponded responsible for this trademark is NICOLE E. GAGE, located at FOLEY & LARDNER LLP, 111 HUNTINGTON AVE, BOSTON MA 02199-7682.

The state or country where the trademark was organized is by Molecular Health Ag. The legal entity type behing it is a Other (Indicates Entity-Statement should appear)., located at Dufourstr. 25, 4010 Basel, zip .

GOODS AND/OR SERVICES
International Class - 035 - Advertising; business management; business administration; office functions.
U.S. Class	102 - Insurance and Financial
Class Status	6 - Active
Status Date	04/04/2012
Primary Code	035
International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
U.S. Class	101 - Advertising and Business
Class Status	6 - Active
Status Date	04/04/2012
Primary Code	042
International Class - 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
U.S. Class	101 - Advertising and Business
Class Status	6 - Active
Status Date	04/04/2012
Primary Code	044
Goods codes
CC0000	Color is not claimed as a feature of the mark.
D10000	"MOLECULAR HEALTH"
DM0000	The mark consists of circle within a circle and an arrow within the inner circle and the word MOLECULARHEALTH to the right of the image.
GS0351	Data collection services for business purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection services for business purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; data and text processing services, namely, the processing of patient specific information, molecular test results and clinical studies data via computer
GS0421	Data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection for research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; scientific, technical and research services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of pharmaceutical side effects, genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of biology, medicine, and bioinformatics; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment research; design and development of databases featuring biomarker data; providing an online searchable database for clinical and scientific research in the field of medical, diagnostic and treatment research; Software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others
GS0441	Providing an online database featuring medical, pharmaceutical and genomic information; pharmaceutical consulting services in pharmaceuticals and genetics in relatin to patient medical treatment options; medical consulting services with respect to the treatment and diagnosis of individuals in the fields of clinical pharmacology and the analysis of dose-effect relationships for treatment purposes; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; medical consulting services in the fields of patient treatment and treatment protocols; consulting services in the field of pharmaceuticals and genetics, namely, conducting drug safety and dosage assessment and in drug compatibility studies in the field of cancer treatment therapy for others
PM0000	MOLECULAR HEALTH

FOREGIN REGISTRATION
Foreign Filing Date	03/06/2012
Foreign Registration Date	03/06/2012
Foreign Expiration Date	03/06/2022
Foreign Application Number	52645/2012
Country	CH
Foreign Registration Number	639786

DESIGN SETUP

Arrows forming a circle or an arc of a circle . Circles as carriers or as single line borders .

PROSECUTION HISTORY
Date	Description	Type	Code
03/20/2014	CORRESPONDENCE RECEIVED IN LAW OFFICE	I - Incoming Correspondence	CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
01/22/2013	TEAS CHANGE OF CORRESPONDENCE RECEIVED	I - Incoming Correspondence	TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/22/2012	NOTIFICATION OF NON-FINAL ACTION E-MAILED	O - Outgoing Correspondence	GNRN
07/22/2012	NON-FINAL ACTION E-MAILED	F - First Action	GNRT - NON-FINAL ACTION E-MAILED
03/20/2014	TEAS/EMAIL CORRESPONDENCE ENTERED	I - Incoming Correspondence	TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
03/14/2014	TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED	I - Incoming Correspondence	ERSI
09/25/2013	NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED	O - Outgoing Correspondence	GNS2
09/25/2013	INQUIRY TO SUSPENSION E-MAILED	S	GNSI - INQUIRY TO SUSPENSION E-MAILED
09/25/2013	SUSPENSION INQUIRY WRITTEN	R - Renewal	CNSI - SUSPENSION INQUIRY - COMPLETED
09/19/2013	LIE CHECKED SUSP - TO ATTY FOR ACTION	S	RCCK - LIE CHECKED SUSP - TO ATTY FOR ACTION
03/14/2013	NOTIFICATION OF LETTER OF SUSPENSION E-MAILED	O - Outgoing Correspondence	GNS3
03/14/2013	LETTER OF SUSPENSION E-MAILED	S	GNSL - LETTER OF SUSPENSION E-MAILED
03/14/2013	SUSPENSION LETTER WRITTEN	R - Renewal	CNSL - SUSPENSION LETTER WRITTEN
03/07/2013	EXAMINER'S AMENDMENT ENTERED	I - Incoming Correspondence	XAEC - EXAMINER'S AMENDMENT ENTERED
03/07/2013	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	O - Outgoing Correspondence	GNEN
03/07/2013	EXAMINERS AMENDMENT E-MAILED	O - Outgoing Correspondence	GNEA - EXAMINERS AMENDMENT E-MAILED
03/07/2013	EXAMINERS AMENDMENT -WRITTEN	R - Renewal	CNEA - EXAMINERS AMENDMENT -WRITTEN
01/31/2013	TEAS/EMAIL CORRESPONDENCE ENTERED	I - Incoming Correspondence	TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
01/31/2013	CORRESPONDENCE RECEIVED IN LAW OFFICE	I - Incoming Correspondence	CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
01/24/2013	ASSIGNED TO LIE	A - Allowance for Publication	ALIE - ASSIGNED TO LIE
01/22/2013	TEAS RESPONSE TO OFFICE ACTION RECEIVED	I - Incoming Correspondence	TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/22/2012	NON-FINAL ACTION WRITTEN	R - Renewal	CNRT - NON-FINAL ACTION WRITTEN
07/10/2012	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
04/05/2012	NOTICE OF DESIGN SEARCH CODE AND PSEUDO MARK MAILED	O - Outgoing Correspondence	MDSM
04/04/2012	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	I - Incoming Correspondence	NWOS
04/02/2012	NEW APPLICATION ENTERED IN TRAM	I - Incoming Correspondence	NWAP - NEW APPLICATION ENTERED IN TRAM

Some parts © 2024 Advameg, Inc.